跳至主要内容
临床试验/CTRI/2021/10/037379
CTRI/2021/10/037379
尚未招募
未知

Role of Oral microbiome and mucosal immunity in COVID-19 disease: diagnostic and prognostic utility in south asian populations(MIMSA) - MIMSA

Department of Bio Technology0 个研究点目标入组 0 人待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
发起方
Department of Bio Technology
状态
尚未招募
最后更新
4年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
4年前
研究类型
Observational

研究者

发起方
Department of Bio Technology

入排标准

入选标准

  • Willing to participate and provide blood and saliva samples at stipulated time points
  • \-Healthy Controls: No history of COVID\-19, not vaccinated, negative for anti\-SARS\-CoV2 nucleoprotein antibodies
  • \-Asymptomatic / symptomatic participants: NPS\-positive by RT\-PCR; disease severity
  • graded as per NIH guidelines

排除标准

  • \-Critically ill participants who cannot give informed consent
  • \-Those who are not willing to get an oral examination done
  • \-Those who cannot chew / drool to provide a SWMF sample due to severe/critical conditions
  • \-Participants with known malignancies and pregnancies
  • \-Participants who are on long\-term immunosuppressants like those with autoimmune

结局指标

主要结局

未指定

相似试验